Immediate Management: Discontinue the Offending Medication
The first and most critical step is to immediately identify and discontinue the oral medication causing these adverse effects, as drug-induced gynecomastia and sexual dysfunction are well-documented side effects of numerous medications and typically resolve upon cessation 1, 2.
Identify the Causative Agent
The most common medications causing both gynecomastia and sexual dysfunction include:
- Spironolactone - definite association with gynecomastia 2
- Cimetidine (now available over-the-counter) - blocks peripheral androgen receptors 1, 2
- Ketoconazole - decreases testosterone production 1, 2
- Anti-androgens (bicalutamide, flutamide, cyproterone acetate) 1, 2
- 5-α reductase inhibitors (finasteride, dutasteride) 2
- Antihypertensives (particularly older agents like reserpine, guanethidine; some β-blockers) 1
- Antipsychotics (risperidone) 2
- Calcium channel blockers (verapamil, nifedipine) 2
- Proton pump inhibitors (omeprazole) 2
- Methotrexate - documented to cause both erectile dysfunction and gynecomastia in rheumatological patients 3
Review all prescription and over-the-counter medications, including antihistamines and decongestants which can impair erectile function 1.
Diagnostic Workup
Physical examination should specifically assess:
- Chest for true glandular gynecomastia versus lipomastia 4
- Testicular examination with ultrasound to rule out testicular tumors (palpation alone has low sensitivity) 5
- Signs of hypogonadism or systemic disease 5
Laboratory investigations 5:
- Morning total testosterone and calculate free/bioavailable testosterone if total is borderline
- Estradiol (E2)
- Sex hormone-binding globulin (SHBG)
- LH and FSH
- Prolactin
- hCG and AFP (to exclude testicular cancer)
- TSH
- Liver and renal function tests
Approximately 45-50% of adult gynecomastia cases have an identifiable underlying pathology 5.
Treatment Algorithm
For Sexual Dysfunction (3 weeks duration):
First-line: PDE5 Inhibitors
Once the offending medication is discontinued, initiate a PDE5 inhibitor (sildenafil, tadalafil, vardenafil, or avanafil) unless contraindicated 6, 7. This is a strong recommendation based on high-quality evidence 6.
- Start conservatively and titrate to maximum dose 4
- Provide explicit instructions: requires sexual stimulation, proper timing relative to meals, adequate trial = 5 separate occasions at maximum dose before declaring failure 4, 7
- Contraindication: concurrent nitrate use (can cause dangerous hypotension) 4
- If first PDE5i fails, try a different one before moving to second-line therapies 7
Address modifiable risk factors 4:
- Smoking cessation
- Weight loss if overweight
- Increase physical activity
- Reduce alcohol consumption
- Screen for depression, anxiety, relationship issues 4
If testosterone deficiency is confirmed: Testosterone replacement therapy may improve sexual function, particularly if hypogonadal 6, 8, 5. However, only 33.3% of men with gynecomastia are actually hypogonadal 9.
For Gynecomastia (1 week duration):
Watchful waiting is recommended after discontinuing the causative medication 5. Most drug-induced gynecomastia will regress spontaneously once the offending agent is stopped 5.
Medical therapy is NOT generally recommended:
- Selective estrogen receptor modulators (SERMs like tamoxifen)
- Aromatase inhibitors
- Non-aromatizable androgens
These are not justified for general use 5. The exception is bicalutamide-induced gynecomastia in prostate cancer patients, where tamoxifen or prophylactic radiation may be appropriate 10.
Surgical intervention is reserved for long-lasting gynecomastia that does not regress spontaneously or following medical therapy 5. Given this patient's gynecomastia is only 1 week old, surgery is premature.
Critical Pitfalls to Avoid
- Do not assume gynecomastia is benign without proper workup - testicular ultrasound is mandatory as palpation misses tumors 5
- Do not prescribe PDE5 inhibitors to patients on nitrates - potentially fatal interaction 4, 7
- Do not declare PDE5i failure without adequate trial - requires 5 attempts at maximum dose with proper technique 4
- Do not ignore cardiovascular risk - erectile dysfunction shares risk factors with cardiovascular disease and may be a predictor 1, 7
- Do not rush to surgery for recent-onset gynecomastia - allow time for spontaneous resolution after medication discontinuation 5
Expected Outcomes
Research demonstrates that surgical correction of gynecomastia significantly improves both hormonal parameters and sexual function scores, with IIEF scores improving from an average of 17.8 preoperatively to 23.5 postoperatively 11, 12. However, this should only be considered after conservative management fails, as the psychological impact of gynecomastia itself may contribute to erectile dysfunction 9, 12.